Sponsor

Baodong Qin

Clinical research sponsor

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLCNCT04116918 · lead sponsor · 2019-09-01

UNKNOWN

Effect of Chemotherapy on PD-L1 in NSCLCNCT03701607 · lead sponsor · 2018-09-01

UNKNOWN

Effect of Chemotherapy on TMB in NSCLCNCT03683407 · lead sponsor · 2018-09-01

UNKNOWN

Sponsor roles

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.